You have right regarding BioC and me however it's not a comparison. According to all accounting standard, you have to show the net (real) revenue, so in every 10-Q the revenue is after discount to wsalers, coupon, etc. (btw: BioC check your calculation ie.: 7/4/2014 12018 $4,136,496.00 should be $2,019,024.00)
1.) Yes, agree and u were conservative. My current guess for script is 8,364 (end of Q2), 14,009 (Q3 w KOWA), 20,084 (Q4 w KOWA).
2.) Yes. I guess (hope) that the current level (11,7 R&D, 20,6 SGA) could be decreased to 8-8,5 R&D, 16-17 SGA), so additional 6,8-8,3M decrease on quaterly basis.
3.) If mission 1 & 2 completed they do not need a partner, they will have enough cash to see the interim result by end of 2016 (data vill be available Q12016).